Curanex Pharmaceuticals CURX Balance Sheet (2024-2026)

NASDAQ CURX
$4.97 -0.06 (-1.29%)
As of: Sep 29, 2026 · 3:50 PM EDT
Reported Financials

Curanex Pharmaceuticals Quarterly Balance Sheet

Periods 6 quarters
Latest Jun 2026

Curanex Pharmaceuticals reported total assets of $5.07M and total liabilities of $0.29M for the quarter ended Jun 2026, up 879.6% year over year. This balance sheet covers 6 quarters of results from Sep 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2024 Dec2024 Jun2025 Sep2025 Dec2025 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 0.24M0.15M0.11M5.83M4.97M2.94M
Cash & Current Investments 0.24M0.15M0.11M5.83M4.97M2.94M
Prepaid Assets 0.00M0.01M8.59M6.25M1.85M
Current Assets 0.52M0.71M14.42M11.23M4.79M
Non-Current Assets
Non-Current Assets 0.08M0.06M0.35M0.28M
Assets 0.52M0.79M14.48M11.58M5.07M
Liabilities
Current Liabilities
Accounts Payables 0.01M269.000.11M0.00M154.00
Payables 0.01M269.000.11M0.00M154.00
Accumulated Expenses 0.01M575.000.01M0.01M0.01M
Other Accumulated Expenses 0.00M
Current Taxes 25.0025.00
Total Current Liabilities 0.01M0.08M0.19M0.14M0.10M
Non-Current Liabilities
Non-Current Debt 0.40M
Operating Leases 0.01M0.22M0.18M
Total Liabilities 0.01M0.48M0.19M0.36M0.29M
Shareholder's Equity
Total Debt 0.40M
Common Equity 0.62M0.50M0.31M14.29M11.22M4.79M
Liabilities and Shareholders Equity 0.52M0.79M14.48M11.58M5.07M
Retained Earnings -0.62M-0.82M-1.77M-4.85M-11.29M
Preferred Shares 100.00100.00100.00100.00100.00

Curanex Pharmaceuticals Balance Sheet API

Pull Curanex Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CURX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY